Quick Answer
Medpace Holdings, Inc. reported Diluted EPS of $15.28 per share for fiscal year 2025.
Medpace Holdings, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $15.28 | +21.0% |
| 2024 | $12.63 | +42.2% |
| 2023 | $8.88 | +22.0% |
| 2022 | $7.28 | +51.4% |
| 2021 | $4.81 | +25.3% |
| 2020 | $3.84 | +43.8% |
| 2019 | $2.67 | +35.5% |
| 2018 | $1.97 | +101.0% |
| 2017 | $0.98 | +164.9% |
| 2016 | $0.37 | +232.1% |
| 2015 | -$0.28 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.86 | +28.2% | +24.5% |
| June 30, 2025 | $3.10 | +12.7% | -15.5% |
| March 31, 2025 | $3.67 | +14.7% | +21.9% |
| September 30, 2024 | $3.01 | +35.6% | +9.5% |
| June 30, 2024 | $2.75 | +42.5% | -14.1% |
| March 31, 2024 | $3.20 | +41.0% | +44.1% |
| September 30, 2023 | $2.22 | +8.3% | +15.0% |
| June 30, 2023 | $1.93 | +32.2% | -15.0% |
- Medpace Holdings, Inc. showed an increase of +21.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2015–2025 period, Medpace Holdings, Inc.’s diluted eps has grown by 5557.1% (from $0.28 per share (loss) to $15.28 per share).
- The most recent figure is from Medpace Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: